Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination

…, G DeBoer, MJ Yaffe, SJ Messner, WS Meschino… - Jama, 2004 - jamanetwork.com
ContextCurrent recommendations for women who have a BRCA1 or BRCA2 mutation are to
undergo breast surveillance from age 25 years onward with mammography annually and …

De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes

…, JL Lauzon, AE Lin, GMS Mancini, WS Meschino… - Nature …, 2012 - nature.com
Megalencephaly-capillary malformation (MCAP) and megalencephaly-polymicrogyria-polydactyly-hydrocephalus
(MPPH) syndromes are sporadic overgrowth disorders associated …

[HTML][HTML] Phenotypic heterogeneity of genomic disorders and rare copy-number variants

…, JS McConnell, B Angle, WS Meschino… - … England Journal of …, 2012 - Mass Medical Soc
Background Some copy-number variants are associated with genomic disorders with
extreme phenotypic heterogeneity. The cause of this variation is unknown, which presents …

Molecular mechanism for duplication 17p11. 2—the homologous recombination reciprocal of the Smith-Magenis microdeletion

…, MA Withers, V Kimonis, AM Summers, WS Meschino… - Nature …, 2000 - nature.com
Recombination between repeated sequences at various loci of the human genome are known
to give rise to DNA rearrangements associated with many genetic disorders 1. Perhaps …

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation

…, L Senter, S Armel, L Bordeleau, WS Meschino… - British journal of …, 2019 - nature.com
Background Women with a BRCA1 or BRCA2 mutation face high risks of breast and ovarian
cancer. In the current study, we report on uptake of cancer screening and risk-reduction …

[PDF][PDF] Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening …

…, M Horgan, JC Carroll, A Eisen, WS Meschino… - J Clin …, 2014 - cancercareontario.ca
Purpose The Ontario Breast Screening Program expanded in July 2011 to screen women
age 30 to 69 years at high risk for breast cancer with annual magnetic resonance imaging (MRI…

Effects of race and ethnicity on perinatal outcomes in high-income and upper-middle-income countries: an individual participant data meta-analysis of 2 198 655 …

…, R Salim, T Huang, A Adank, J Zhang, WS Meschino… - The Lancet, 2022 - thelancet.com
Background Existing evidence on the effects of race and ethnicity on pregnancy outcomes is
restricted to individual studies done within specific countries and health systems. We aimed …

BAFopathies' DNA methylation epi-signatures demonstrate diagnostic utility and functional continuum of Coffin–Siris and Nicolaides–Baraitser syndromes

…, DJ Callen, AM Innes, SM White, WS Meschino… - Nature …, 2018 - nature.com
Coffin–Siris and Nicolaides–Baraitser syndromes (CSS and NCBRS) are Mendelian disorders
caused by mutations in subunits of the BAF chromatin remodeling complex. We report …

Not on the face alone: perception of contextualized face expressions in Huntington's disease

…, WS Meschino, J Kennedy, S Grewal, S Esmail… - Brain, 2009 - academic.oup.com
Numerous studies have demonstrated that Huntington's disease mutation-carriers have
deficient explicit recognition of isolated facial expressions. There are no studies, however, which …

Genotype–phenotype analysis of the branchio‐oculo‐facial syndrome

…, WS Meschino, GR Mortier, S Parkash… - American Journal of …, 2011 - Wiley Online Library
Branchio‐oculo‐facial syndrome (BOFS; OMIM#113620) is a rare autosomal dominant
craniofacial disorder with variable expression. Major features include cutaneous and ocular …